Randomized Trial to Test Effect of Rivaroxaban or Apixaban on Menstrual Blood Loss in Women (RAMBLE)

Trial Profile

Randomized Trial to Test Effect of Rivaroxaban or Apixaban on Menstrual Blood Loss in Women (RAMBLE)

Recruiting
Phase of Trial: Phase II/III

Latest Information Update: 13 Oct 2016

At a glance

  • Drugs Apixaban (Primary) ; Rivaroxaban
  • Indications Atrial fibrillation; Venous thromboembolism
  • Focus Adverse reactions
  • Acronyms RAMBLE
  • Most Recent Events

    • 07 Oct 2016 Status changed from not yet recruiting to recruiting.
    • 07 Oct 2016 Status changed from not yet recruiting to recruiting.
    • 06 May 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top